Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

This study has been completed.

Study NCT00653055 Information provided by Par Pharmaceutical, Inc.

First Received: April 1, 2008 Last Updated: April 3, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2001
Primary Completion Date:	December 2001 (Final data collection date for primary outcome measure)